Astrazeneca was the leading pharmaceutical company in the United Kingdom as of March 7, 2024, with a market capitalization amounting to approximately 202.4 billion U.S. dollars. GlaxoSmithKline followed as the second largest pharma company in the country, with market capitalization of nearly 86.7 billion U.S. dollars. Examining the development of the FTSE 100 Index, which was launched in January 1984 with a base level of 1,000, increased by more than sevenfold to date. What is the FTSE 100 index? The Financial Times Stock Exchange 100 Index, commonly known as the "Footsie", is the most widely recognized stock market index in the United Kingdom. It is made up of the 100 largest blue-chip companies on the London Stock Exchange. Companies from various sectors, such as healthcare, consumer goods, and energy, are included in the index, as are leading banks of the United Kingdom, such as HSBC, Lloyds Banking Group, and Barclays. Moreover, it can be seen as a reflection of the investment climate in the United Kingdom. What is not included in the FTSE 100 Index? Most notably, the FTSE 100 Index, like most indices, is not adjusted for inflation. While inflation in the United Kingdom has gone down dramatically since 2023, it might be useful to adjust the historic figures on the index when comparing historic data to current levels. This is especially important when the index seems to have increased by a few percentage points because inflation may have increased at a faster rate than stock prices.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
The main stock market index in the United Kingdom (GB100) increased 479 points or 5.86% since the beginning of 2025, according to trading on a contract for difference (CFD) that tracks this benchmark index from United Kingdom. United Kingdom Stock Market Index (GB100) - values, historical data, forecasts and news - updated on March of 2025.
https://www.kappasignal.com/p/legal-disclaimer.htmlhttps://www.kappasignal.com/p/legal-disclaimer.html
This analysis presents a rigorous exploration of financial data, incorporating a diverse range of statistical features. By providing a robust foundation, it facilitates advanced research and innovative modeling techniques within the field of finance.
Historical daily stock prices (open, high, low, close, volume)
Fundamental data (e.g., market capitalization, price to earnings P/E ratio, dividend yield, earnings per share EPS, price to earnings growth, debt-to-equity ratio, price-to-book ratio, current ratio, free cash flow, projected earnings growth, return on equity, dividend payout ratio, price to sales ratio, credit rating)
Technical indicators (e.g., moving averages, RSI, MACD, average directional index, aroon oscillator, stochastic oscillator, on-balance volume, accumulation/distribution A/D line, parabolic SAR indicator, bollinger bands indicators, fibonacci, williams percent range, commodity channel index)
Feature engineering based on financial data and technical indicators
Sentiment analysis data from social media and news articles
Macroeconomic data (e.g., GDP, unemployment rate, interest rates, consumer spending, building permits, consumer confidence, inflation, producer price index, money supply, home sales, retail sales, bond yields)
Stock price prediction
Portfolio optimization
Algorithmic trading
Market sentiment analysis
Risk management
Researchers investigating the effectiveness of machine learning in stock market prediction
Analysts developing quantitative trading Buy/Sell strategies
Individuals interested in building their own stock market prediction models
Students learning about machine learning and financial applications
The dataset may include different levels of granularity (e.g., daily, hourly)
Data cleaning and preprocessing are essential before model training
Regular updates are recommended to maintain the accuracy and relevance of the data
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
A number of methods of evaluating the validity of interval forecasts of financial data are analysed, and illustrated using intraday FTSE100 index futures returns. Some existing interval forecast evaluation techniques, such as the Markov chain approach of Christoffersen (1998), are shown to be inappropriate in the presence of periodic heteroscedasticity. Instead, we consider a regression-based test, and a modified version of Christoffersen's Markov chain test for independence, and analyse their properties when the financial time series exhibit periodic volatility. These approaches lead to different conclusions when interval forecasts of FTSE100 index futures returns generated by various GARCH(1,1) and periodic GARCH(1,1) models are evaluated.
We investigate high-frequency reactions in the Eurozone stock market and the UK stock market during the time period surrounding the European Central Bank (ECB) and the Bank of England (BoE)'s interest rate decisions assessing how these two markets react and co-move influencing each other.
The effects are quantified by measuring linear and non-linear transfer entropy combined with a Bivariate Empirical Mode Decomposition (BEMD) from a dataset of 1-minute prices for the Euro Stoxx 50 and the FTSE 100 stock indices.
We uncover that central banks' interest rate decisions induce an upsurge in intraday volatility that is more pronounced on ECB announcement days and there is a significant information flow between the markets with prevalent direction going from the market where the announcement is made towards the other.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Middle panel: pairs of wavelet levels with statistically different values for their correlation coefficients, by period and pair of financial markets. Right panel: wavelet level where the difference of two correlation coefficients is the largest, by pair of periods and pair of financial markets.*Wavelet level n corresponding to 2n-1 trading days.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Astrazeneca was the leading pharmaceutical company in the United Kingdom as of March 7, 2024, with a market capitalization amounting to approximately 202.4 billion U.S. dollars. GlaxoSmithKline followed as the second largest pharma company in the country, with market capitalization of nearly 86.7 billion U.S. dollars. Examining the development of the FTSE 100 Index, which was launched in January 1984 with a base level of 1,000, increased by more than sevenfold to date. What is the FTSE 100 index? The Financial Times Stock Exchange 100 Index, commonly known as the "Footsie", is the most widely recognized stock market index in the United Kingdom. It is made up of the 100 largest blue-chip companies on the London Stock Exchange. Companies from various sectors, such as healthcare, consumer goods, and energy, are included in the index, as are leading banks of the United Kingdom, such as HSBC, Lloyds Banking Group, and Barclays. Moreover, it can be seen as a reflection of the investment climate in the United Kingdom. What is not included in the FTSE 100 Index? Most notably, the FTSE 100 Index, like most indices, is not adjusted for inflation. While inflation in the United Kingdom has gone down dramatically since 2023, it might be useful to adjust the historic figures on the index when comparing historic data to current levels. This is especially important when the index seems to have increased by a few percentage points because inflation may have increased at a faster rate than stock prices.